Takeda Pharmaceutical Co., Ltd. v. Mylan Inc.
5:13-cv-04002
Overview
Parties
Defendant
Mylan Inc. Operating Company
Represented By
4 Attorneys ListedAlston & Bird LLP
90 Park Avenue, New York, NY 10016-1387
Alston & Bird LLP
90 Park Avenue, New York, NY 10016-1387
Alston & Bird LLP
333 South Hope Street, 16th Floor
Plaintiff
Takeda Pharmaceuticals America, Inc Operating Company
Represented By
6 Attorneys ListedMunger, Tolles and Olson LLP
355 S. Grand Ave., 35th FL, Los Angeles, CA 90071
Munger, Tolles & Olson LLP
560 Mission Street, San Francisco, CA 94105
Munger, Tolles and Olson LLP
560 Mission Street, 27th Floor
Munger, Tolles & Olson LLP
355 South Grand Ave., #3500, Los Angeles, CA 90071
Munger Tolles & Olson LLP
355 South Grand Avenue, Thirty-Fifth Floor
Munger, Tolles and Olson LLP
355 S Grand Ave 35th Fl, Los Angeles, CA 90071
Takeda Pharmaceuticals U.S.A., Inc. Operating Company
Represented By
6 Attorneys ListedMunger, Tolles and Olson LLP
355 S. Grand Ave., 35th FL, Los Angeles, CA 90071
Munger, Tolles & Olson LLP
560 Mission Street, San Francisco, CA 94105
Munger, Tolles and Olson LLP
560 Mission Street, 27th Floor
Munger, Tolles & Olson LLP
355 South Grand Ave., #3500, Los Angeles, CA 90071
Munger Tolles & Olson LLP
355 South Grand Avenue, Thirty-Fifth Floor
Munger, Tolles and Olson LLP
355 S Grand Ave 35th Fl, Los Angeles, CA 90071
Takeda Pharmaceutical Co., Ltd. Operating Company
Represented By
6 Attorneys ListedMunger, Tolles and Olson LLP
355 S. Grand Ave., 35th FL, Los Angeles, CA 90071
Munger, Tolles & Olson LLP
560 Mission Street, San Francisco, CA 94105
Munger, Tolles and Olson LLP
560 Mission Street, 27th Floor
Munger, Tolles & Olson LLP
355 South Grand Ave., #3500, Los Angeles, CA 90071
Munger Tolles & Olson LLP
355 South Grand Avenue, Thirty-Fifth Floor
Munger, Tolles and Olson LLP
355 S Grand Ave 35th Fl, Los Angeles, CA 90071
Counter-Claimant
Mylan Pharmaceuticals Inc. Operating Company
Represented By
4 Attorneys ListedAlston & Bird LLP
90 Park Avenue, New York, NY 10016-1387
Alston & Bird LLP
90 Park Avenue, New York, NY 10016-1387
Alston & Bird LLP
333 South Hope Street, 16th Floor
Court & Judges
Court
District Court, N.D. California (cand)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 13 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇯🇵 Japan | Japan Counterpart | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6939971
Benzimidazole compound crystal
|
Filed: 2003-09-04
Issued: 2005-09-06
|
Expired (Term Ended)
Expires: 2023-09-04
|
|
|
US7339064
Benzimidazole compound crystal
|
Filed: 2005-06-10
Issued: 2008-03-04
|
Expired (Term Ended)
Expires: 2025-06-10
|
|
|
US8173158
Methods of treating gastrointestinal disorders independent of the intake of food
|
Filed: 2008-10-10
Issued: 2012-05-08
|
Active (3.3 yrs remaining)
+523d PTA
Expires: 2030-03-17
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
10
Dispositive
1
Granted
0
Denied
0
Pending / Review
7
Motions by Category
Key Dispositive Motions & Rulings